These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 18682976)

  • 41. The tumor necrosis factor superfamily members TWEAK, TNFSF15 and fibroblast growth factor-inducible protein 14 are upregulated in proliferative diabetic retinopathy.
    Abu El-Asrar AM; De Hertogh G; Nawaz MI; Siddiquei MM; Van den Eynde K; Mohammad G; Opdenakker G; Geboes K
    Ophthalmic Res; 2015; 53(3):122-30. PubMed ID: 25676319
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Lipopolysaccharide-binding protein and soluble CD14 in the vitreous fluid of patients with proliferative diabetic retinopathy.
    Hernández C; Ortega F; García-Ramírez M; Villarroel M; Casado J; García-Pascual L; Fernández-Real JM; Simó R
    Retina; 2010 Feb; 30(2):345-52. PubMed ID: 20175275
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Vitreous levels of interleukin-8 in patients with proliferative diabetic retinopathy.
    Petrovic MG; Korosec P; Kosnik M; Hawlina M
    Am J Ophthalmol; 2007 Jan; 143(1):175-6. PubMed ID: 17188064
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Soluble TNF receptors in vitreoretinal proliferative disease.
    Limb GA; Hollifield RD; Webster L; Charteris DG; Chignell AH
    Invest Ophthalmol Vis Sci; 2001 Jun; 42(7):1586-91. PubMed ID: 11381065
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comparison of serum NO, TNF-alpha, IL-1beta, sIL-2R, IL-6 and IL-8 levels with grades of retinopathy in patients with diabetes mellitus.
    Doganay S; Evereklioglu C; Er H; Türköz Y; Sevinç A; Mehmet N; Savli H
    Eye (Lond); 2002 Mar; 16(2):163-70. PubMed ID: 11988817
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Vascular endothelial growth factor concentration in vitreous humor of patients with severe proliferative diabetic retinopathy after intravitreal injection of conbercept as an adjunctive therapy for vitrectomy.
    Li B; Li MD; Ye JJ; Chen Z; Guo ZJ; Di Y
    Chin Med J (Engl); 2020 Mar; 133(6):664-669. PubMed ID: 32068603
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Soluble IL-6 receptor in vitreous fluid of patients with proliferative diabetic retinopathy.
    Kawashima M; Shoji J; Nakajima M; Kamura Y; Sato Y
    Jpn J Ophthalmol; 2007; 51(2):100-4. PubMed ID: 17401618
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Proinflammatory cytokines and angiogenic and anti-angiogenic factors in vitreous of patients with proliferative diabetic retinopathy and eales' disease.
    Murugeswari P; Shukla D; Rajendran A; Kim R; Namperumalsamy P; Muthukkaruppan V
    Retina; 2008 Jun; 28(6):817-24. PubMed ID: 18536597
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Increased vitreous levels of hydroimidazolone in type 2 diabetes patients are associated with retinopathy: a case-control study.
    Fosmark DS; Bragadóttir R; Stene-Johansen I; Berg JP; Berg TJ; Lund T; Sandvik L; Hanssen KF
    Acta Ophthalmol Scand; 2007 Sep; 85(6):618-22. PubMed ID: 17488318
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Intravitreous leptin concentrations in patients with proliferative diabetic retinopathy.
    Hernández C; Lecube A; Castellanos JM; Segura RM; Garat M; García-Arumí J; Simó R
    Retina; 2004 Feb; 24(1):30-5. PubMed ID: 15076941
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Vitreous levels of vascular endothelial growth factor are not influenced by its serum concentrations in diabetic retinopathy.
    Burgos R; Simó R; Audí L; Mateo C; Mesa J; García-Ramírez M; Carrascosa A
    Diabetologia; 1997 Sep; 40(9):1107-9. PubMed ID: 9300249
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Platelet expression of tumour necrosis factor-alpha (TNF-alpha), TNF receptors and intercellular adhesion molecule-1 (ICAM-1) in patients with proliferative diabetic retinopathy.
    Limb GA; Webster L; Soomro H; Janikoun S; Shilling J
    Clin Exp Immunol; 1999 Nov; 118(2):213-8. PubMed ID: 10540181
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Vitreous intercellular adhesion molecule 1 in uveitis complicated by retinal detachment.
    Webster L; Stanbury RM; Chignell AH; Limb GA
    Br J Ophthalmol; 1998 Apr; 82(4):438-43. PubMed ID: 9640197
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Levels of Interleukin 27 and Interleukin 35 in the Serum and Vitreous of Patients with Proliferative Diabetic Retinopathy.
    Yan A; You H; Zhang X
    Ocul Immunol Inflamm; 2018; 26(2):273-279. PubMed ID: 27537610
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Vitreous vascular endothelial growth factor concentrations in proliferative diabetic retinopathy versus proliferative vitreoretinopathy.
    Citirik M; Kabatas EU; Batman C; Akin KO; Kabatas N
    Ophthalmic Res; 2012; 47(1):7-12. PubMed ID: 21691136
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Altered oxylipin levels in human vitreous indicate imbalance in pro-/anti-inflammatory homeostasis in proliferative diabetic retinopathy.
    Zhao T; Wang Y; Guo X; Li H; Jiang W; Xiao Y; Deng B; Sun Y
    Exp Eye Res; 2022 Jan; 214():108799. PubMed ID: 34687725
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Vitreous levels of vascular endothelial growth factor and intercellular adhesion molecule 1 are related to diabetic macular edema.
    Funatsu H; Yamashita H; Sakata K; Noma H; Mimura T; Suzuki M; Eguchi S; Hori S
    Ophthalmology; 2005 May; 112(5):806-16. PubMed ID: 15878060
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Elevated serum levels of soluble vascular cell adhesion molecule-1 in NIDDM patients with proliferative diabetic retinopathy.
    Yoshizawa M; Nagai Y; Ohsawa K; Ohta M; Yamashita H; Hisada A; Miyamoto I; Miura K; Takamura T; Kobayashi K
    Diabetes Res Clin Pract; 1998 Oct; 42(1):65-70. PubMed ID: 9884035
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Inflammation and N-formyl peptide receptors mediate the angiogenic activity of human vitreous humour in proliferative diabetic retinopathy.
    Rezzola S; Corsini M; Chiodelli P; Cancarini A; Nawaz IM; Coltrini D; Mitola S; Ronca R; Belleri M; Lista L; Rusciano D; De Rosa M; Pavone V; Semeraro F; Presta M
    Diabetologia; 2017 Apr; 60(4):719-728. PubMed ID: 28083635
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Assessment of Neurotrophins and Inflammatory Mediators in Vitreous of Patients With Diabetic Retinopathy.
    Boss JD; Singh PK; Pandya HK; Tosi J; Kim C; Tewari A; Juzych MS; Abrams GW; Kumar A
    Invest Ophthalmol Vis Sci; 2017 Oct; 58(12):5594-5603. PubMed ID: 29084332
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.